Daily Insurance Industry News
Daily Insurance Industry News
Friday 26th of April 2019
June 16, 2008

Corporate PMI cover lacks clarity on cancer cover

by Gill Montia

Story link: Corporate PMI cover lacks clarity on cancer cover

Corporate PMI cover lacks clarity on cancer cover Corporate PMI cover lacks clarity on cancer cover

Private medical insurance providers (PMI) have been criticised for being less than clear about the cover they provide for members of company health insurance schemes who develop cancer.

Employee benefit consultant Mercer and charity Cancerbackup, have examined the corporate medical insurance offered by 11 leading UK PMI providers for transparency and clarity in the terms they use in connection with the disease.

They have also looked at the scope and standard of the treatments included in the cover and the limits on cover.

The findings have been published in a study entitled “Covering Cancer: Survey of Corporate healthcare/Private Medical Insurance (PMI) providers”, which highlights some of the problems.

For example, the eligibility rules for chronic conditions contained in some policies could mean that some cancer treatments are excluded or cut short.

This is particularly relevant in the case of new cancer treatments that slow the spread of the disease rather than cure it.

The research found that PMI providers frequently use the phrase “active treatment” which could discount palliative care or treatment for terminal cancer.

The report commended a number of plans , including: AXA’s Corporate Healthcare VIP and Executive Plan (which provides optional enhanced cancer cover); Bupa Premier Insurance and the Prudential Health Comprehensive policy. All meet Cancerbackup’s Gold Standard.

The charity points out that while buying the best cover available is optional, clarity about what is and is not covered under a policy is essential.

Current levels of the disease suggest that one in three people in the UK will be diagnosed with cancer at some stage during their life.


News posted:

Related stories to Corporate PMI cover lacks clarity on cancer cover: